51919-71-2 Usage
Uses
Used in Organic Synthesis:
Methyl 4-(methylsulfanyl)-3-nitrobenzenecarboxylate is used as a reagent in organic synthesis for the preparation of various organic compounds. Its versatile reactivity and mild performance make it a preferred choice in a wide range of reactions.
Used in Pharmaceutical Production:
Methyl 4-(methylsulfanyl)-3-nitrobenzenecarboxylate is used as a building block in the production of pharmaceuticals. Its potential applications in medicinal chemistry and other research fields make it a valuable component in the development of new drugs.
Used in Agrochemical Production:
Methyl 4-(methylsulfanyl)-3-nitrobenzenecarboxylate is also used as a building block in the production of agrochemicals. Its versatility and reactivity contribute to the development of effective and efficient agrochemical products.
Used in Fine Chemicals Production:
Methyl 4-(methylsulfanyl)-3-nitrobenzenecarboxylate is utilized in the production of other fine chemicals. Its unique structure and functional groups make it a valuable component in the synthesis of specialty chemicals for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 51919-71-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,9,1 and 9 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 51919-71:
(7*5)+(6*1)+(5*9)+(4*1)+(3*9)+(2*7)+(1*1)=132
132 % 10 = 2
So 51919-71-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO4S/c1-14-9(11)6-3-4-8(15-2)7(5-6)10(12)13/h3-5H,1-2H3
51919-71-2Relevant academic research and scientific papers
COMPOUNDS CONTAINING PHENYL LINKED TO ARYL OR HETEROARYL BY AN ALIPHATIC- OR HETEROATOM-CONTAINING LINKING GROUP
-
, (2008/06/13)
This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group
-
, (2008/06/13)
This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase.
ACAT inhibitory benzanilides
-
, (2008/06/13)
Benzanilide derivatives of the formula: STR1 wherein R1 is alkyl optionally containing double or triple bonds, and optionally interrupted by one or more hetero atoms; R2 is hydrogen, methyl, or ethyl; R3 is halogen, alkyl,
